checkAd
    Startseite > Aktien > Silence Therapeutics > Nachrichten
    Silence Therapeutics Aktie
    6,1900
     
    EUR
    -0,32 %
    -0,0200 EUR
    Letzter Kurs 30.11.21 Lang & Schwarz
    6,0600
     
    EUR
    805 STK
    Geldkurs 30.11.21
    6,3200
     
    EUR
    805 STK
    Briefkurs 30.11.21
    ISIN: GB00B9GTXM62 · WKN: A1T9PD · Großbritannien

    Neueste Nachrichten

    Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright 2nd Annual BioConnect Investor Conference
    30.04.24 · Business Wire (engl.) · Silence Therapeutics
    Silence Therapeutics Announces Retirement of Alistair Gray from Board of Directors
    29.04.24 · Business Wire (engl.) · Silence Therapeutics
    Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a)
    08.04.24 · Business Wire (engl.) · Silence Therapeutics
    Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights
    13.03.24 · Business Wire (engl.) · Silence Therapeutics
    Silence Therapeutics Announces Positive Topline 36-Week Data from Ongoing Phase 2 Study of Zerlasiran in Patients with High Lipoprotein(a)
    13.03.24 · Business Wire (engl.) · Silence Therapeutics
    Silence Therapeutics to Report Fourth Quarter and Full Year 2023 Results on March 13, 2024
    28.02.24 · Business Wire (engl.) · Silence Therapeutics
    Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration Following the Initiation of Phase 1 Trial
    23.02.24 · Business Wire (engl.) · Silence Therapeutics
    Silence Therapeutics Announces Oversubscribed $120 Million Private Placement
    05.02.24 · Business Wire (engl.) · Silence Therapeutics
    Silence Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
    31.01.24 · Business Wire (engl.) · Silence Therapeutics
    Silence Therapeutics Strengthens Executive Leadership Team with Key Appointments
    01.12.23 · Business Wire (engl.) · Silence Therapeutics
    Silence Therapeutics Highlights Recent Company Progress and Reports Third Quarter 2023 Financial Results
    14.11.23 · Business Wire (engl.) · Silence Therapeutics
    Silence Therapeutics to Present at Jefferies London Healthcare Conference
    08.11.23 · Business Wire (engl.) · Silence Therapeutics